...mL correlated with significant improvements in "multiple pulmonary function and emphysema symptom endpoints." Angiotech granted Broncus...
...system in 2005 (see BioCentury, June 6, 2005). Angiotech Pharmaceuticals Inc. (TSX:ANP; NASDAQ:ANPI), Vancouver, B.C. Broncus...

...and reimbursement claims. Last week, Abingworth also participated in the $38 million financing completed by Broncus...
...Charter Ventures; HBM BioVentures JAIC America; Menlo Ventures; Pac-Link Ventures; Saints Capital and Sightline Ventures. Broncus'...

...ANP granted Broncus a worldwide, non-exclusive license to use paclitaxel technology with Broncus' Exhale system to...
...ANP will receive an upfront payment and milestones in the form of warrants to purchase Broncus...
...preferred stock. ANP also is eligible for royalties. Angiotech Pharmaceuticals Inc. (TSE:ANP; ANPI), Vancouver, B.C. Broncus...